The regulation of transient receptor potential canonical 4 (TRPC4) channel by phosphodiesterase 5 inhibitor via the cyclic guanosine 3′5′-monophosphate

(−)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels

(2015) Yasemin Akbulut et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Dexamethasone activates transient receptor potential canonical 4 (TRPC4) channels via Rasd1 small GTPase pathway

(2014) Jinhong Wie et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Increased expression of TRPC4 channels associated with erectile dysfunction in diabetes

(2014) H. H. Sung et al.   Andrology

Activation of TRPC4β by Gαi subunit increases Ca2+ selectivity and controls neurite morphogenesis in cultured hippocampal neuron

(2013) Jae-Pyo Jeon et al.   CELL CALCIUM

PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS

(2013) Linda Vignozzi et al.   PROSTATE

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

(2012) Mauro Gacci et al.   EUROPEAN UROLOGY

Mass spectrometric analysis of novel phosphorylation sites in the TRPC4β channel

(2012) Ji Eun Lee et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels

(2011) Melissa Miller et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation

(2009) Jie Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia

(2009) Chunyu Wang   CURRENT OPINION IN UROLOGY

Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture

(2008) Roberto Berra-Romani et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds

(2008) Peter Wong et al.   CURRENT OPINION IN UROLOGY

Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6

(2008) Shinichi Takahashi et al.   JOURNAL OF PHYSIOLOGY-LONDON

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

(2008) George T. Kedia et al.   WORLD JOURNAL OF UROLOGY